Cell and Tissue Preservation

Global Cell and Tissue Preservation Market to Reach US$9.3 Billion by 2030

The global market for Cell and Tissue Preservation estimated at US$5.0 Billion in the year 2024, is expected to reach US$9.3 Billion by 2030, growing at a CAGR of 11.0% over the analysis period 2024-2030. Cell, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$6.4 Billion by the end of the analysis period. Growth in the Tissue segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 15.2% CAGR

The Cell and Tissue Preservation market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 15.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.9% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.7% CAGR.

Global Cell and Tissue Preservation Market – Key Trends & Drivers Summarized

Why Is Cell and Tissue Preservation Becoming Foundational to Biomedical Research, Regenerative Therapies, and Biobanking Infrastructure?
Cell and tissue preservation technologies are emerging as critical enablers of scientific progress, clinical innovation, and scalable biobanking. The ability to maintain cellular integrity, viability, and function during storage, transportation, and future use is vital for applications ranging from organ transplantation and stem cell therapy to cancer research and personalized medicine. As demand intensifies for high-quality biological samples in both R&D and clinical settings, preservation systems are becoming core infrastructure for precision healthcare and life science advancement.

The expansion of cell-based therapeutics, cryobanking, and diagnostic applications is driving systematic adoption across hospitals, academic institutions, pharmaceutical firms, and contract research organizations (CROs). Tissue engineering, fertility preservation, and immunotherapy protocols increasingly rely on cryopreservation, vitrification, and hypothermic storage methods to ensure time-flexible and geographically scalable treatment models. As the biotech and regenerative medicine sectors mature, effective preservation is transitioning from a back-end process to a strategic determinant of clinical and commercial viability.

How Are Cryopreservation Techniques, Media Formulations, and Equipment Innovation Advancing the Market?
Technological advancements are improving the precision, scalability, and efficacy of preservation protocols. Cryopreservation using ultra-low temperature storage in liquid nitrogen remains the gold standard for long-term viability of cells and tissues. Innovations in vitrification—rapid freezing without ice crystal formation—are enhancing survival rates of sensitive cells such as oocytes, stem cells, and embryonic tissues.

The development of specialized cryoprotective agents (CPAs) and storage media—free of serum, DMSO, or animal-origin components—is addressing cytotoxicity concerns and regulatory requirements for clinical-grade applications. Sophisticated freezing and thawing equipment with programmable temperature control, automated vial handling, and contamination safeguards are optimizing sample consistency and traceability.

Emerging areas such as room-temperature preservation via lyophilization, hydrogel encapsulation, and nanoparticle-mediated cryoprotection are expanding the toolkit for future-proof storage with reduced cold chain dependence. Integration of monitoring sensors, digital inventory systems, and compliance software is making preservation workflows more secure, efficient, and GMP-aligned.

Which Application Domains, Regional Hotspots, and Industry Participants Are Shaping the Growth of Cell and Tissue Preservation?
The market serves a wide range of applications spanning stem cell banking, organ and tissue transplant logistics, cancer biobanking, reproductive medicine, and cell-based assay development. Biopharmaceutical companies are leveraging preservation techniques for cell line maintenance, biologics production, and clinical trial sample management. Fertility clinics, academic research centers, and veterinary services are also expanding their reliance on high-performance preservation tools.

North America leads in adoption due to its advanced biopharma ecosystem, robust transplant programs, and established stem cell networks. Europe follows with strong biobanking initiatives and a supportive regulatory framework. Asia-Pacific is witnessing rapid expansion, driven by growing investment in cell therapy, expanding fertility treatment markets, and rising clinical trial activity—especially in countries like China, Japan, India, and South Korea.

Key players include Thermo Fisher Scientific, BioLife Solutions, Merck KGaA, Sartorius, and Cryoport, along with a growing cohort of regional specialists and academic spin-offs. Industry focus areas include GMP-compliant reagents, cold chain logistics integration, and scalable cryo-infrastructure for clinical and commercial use. Strategic collaborations between biobanks, pharma companies, and healthcare providers are accelerating the deployment of preservation systems in both developed and emerging markets.

What Are the Factors Driving Growth in the Cell and Tissue Preservation Market?
The market is advancing in response to surging demand for reproducible, long-term biological storage solutions that support personalized therapies, global research collaboration, and cell-based drug development. As medical innovation becomes increasingly reliant on high-integrity biospecimens, preservation is moving from a support function to a strategic enabler.

Key growth drivers include expanding cell therapy pipelines, increased demand for off-the-shelf biological materials, advancements in cryopreservation technologies, and the globalization of clinical research. Regulatory emphasis on traceability and biosafety, combined with investments in biobank standardization and digitization, further reinforces market momentum.

As biomedicine evolves toward personalized, cell-driven therapies and distributed research models, could cell and tissue preservation become the keystone of scalable, future-ready healthcare infrastructure?

SCOPE OF STUDY:

The report analyzes the Cell and Tissue Preservation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Cell, Tissue); Product (Equipment, Software, Bio-Preservation Media, Home-Brew Media, Pre-Formulated Media); Application (Therapeutics, Drug Discovery, Gene Therapy, IVF treatment, Cell Therapy, Research & Development); End-User (Biobanks & Cell banks, Hospitals & Diagnostics Labs, Research Laboratories, Other End-Users); Preservation Technique (Cryopreservation, Ambient Temperature Storage, Temperature-Controlled Storage, Drying / Freeze-Drying, Radiation, Other Preservation Techniques)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• 21st Century Medicine
• Agilent Technologies, Inc.
• AllCells
• AMSBIO
• Avantor, Inc.
• BioLife Solutions, Inc.
• Biocell Center
• Biomatrica
• CellGenix GmbH
• Cells4Life
• Corning Incorporated
• Cryo-Cell International
• Cytiva
• FUJIFILM Irvine Scientific
• LGC SeraCare
• Lonza Group AG
• Merck KGaA
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.
• Tissue Regenix Group

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.